Allstate Corporation’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.9M | Buy |
80,947
+23,889
| +42% | +$2.13M | 0.07% | 175 |
|
|
2025
Q4 | $4.51M | Buy |
57,058
+29,108
| +104% | +$2.28M | 0.06% | 201 |
|
|
2025
Q3 | $2.23M | Buy |
+27,950
| New | +$2.38M | 0.05% | 201 |
|
|
2025
Q2 | – | Sell |
-38,063
| Closed | -$3.57M | – | 243 |
|
|
2025
Q1 | $3.57M | Buy |
38,063
+15,104
| +66% | +$1.35M | 0.1% | 122 |
|
|
2024
Q4 | $2.09M | Buy |
+22,959
| New | +$2.19M | 0.06% | 173 |
|
|
2024
Q3 | – | Sell |
-2,356
| Closed | -$229K | – | 134 |
|
|
2024
Q2 | $229K | Hold |
2,356
| – | – | 0.02% | 196 |
|
|
2024
Q1 | $212K | Buy |
+2,356
| New | +$200K | 0.02% | 214 |
|
|
2023
Q1 | – | Sell |
-23,543
| Closed | -$1.85M | – | 269 |
|
|
2022
Q4 | $1.85M | Sell |
23,543
-7,024
| -23% | -$527K | 0.06% | 205 |
|
|
2022
Q3 | $2.15M | Buy |
30,567
+4,100
| +15% | +$321K | 0.06% | 179 |
|
|
2022
Q2 | $2.12M | Buy |
26,467
+16,139
| +156% | +$1.26M | 0.07% | 178 |
|
|
2022
Q1 | $783K | Sell |
10,328
-51,247
| -83% | -$4.06M | 0.02% | 443 |
|
|
2021
Q4 | $5.25M | Buy |
61,575
+54,047
| +718% | +$4.22M | 0.1% | 157 |
|
|
2021
Q3 | $569K | Sell |
7,528
-1,125
| -13% | -$89.3K | 0.02% | 482 |
|
|
2021
Q2 | $704K | Sell |
8,653
-1,000
| -10% | -$81.8K | 0.02% | 421 |
|
|
2021
Q1 | $761K | Sell |
9,653
-1,006
| -9% | -$78.9K | 0.02% | 396 |
|
|
2020
Q4 | $911K | Buy |
10,659
+1,311
| +14% | +$108K | 0.03% | 303 |
|
|
2020
Q3 | $721K | Sell |
9,348
-3,194
| -25% | -$244K | 0.02% | 318 |
|
|
2020
Q2 | $919K | Buy |
+12,542
| New | +$891K | 0.03% | 270 |
|
|
2020
Q1 | – | Sell |
-35,072
| Closed | -$2.41M | – | 627 |
|
|
2019
Q4 | $2.41M | Sell |
35,072
-1,492
| -4% | -$102K | 0.04% | 261 |
|
|
2019
Q3 | $2.69M | Sell |
36,564
-31,842
| -47% | -$2.31M | 0.05% | 226 |
|
|
2019
Q2 | $4.9M | Buy |
68,406
+18,081
| +36% | +$1.28M | 0.09% | 133 |
|
|
2019
Q1 | $3.45M | Buy |
50,325
+14,948
| +42% | +$966K | 0.09% | 160 |
|
|
2018
Q4 | $2.11M | Buy |
+35,377
| New | +$2.21M | 0.07% | 216 |
|
|
2017
Q1 | – | Sell |
-60,599
| Closed | -$3.97M | – | 191 |
|
|
2016
Q4 | $3.97M | Buy |
60,599
+44,572
| +278% | +$3.06M | 0.24% | 122 |
|
|
2016
Q3 | $1.19M | Buy |
16,027
+11,241
| +235% | +$831K | 0.08% | 144 |
|
|
2016
Q2 | $350K | Buy |
+4,786
| New | +$341K | 0.02% | 154 |
|
Other funds holding CL
VCM
DAM
VPM
Allstate Corporation's CL Position: Q1 2026 in Review
Allstate Corporation increased its Colgate-Palmolive (CL) stake by 42% in Q1 2026, buying an estimated $2.13M and bringing the position to 80,947 shares worth $6.9M. The position accounts for 0.07% of the portfolio, ranked #175.
Allstate Corporation first reported a position in CL in Q2 2016 and has held it in 26 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Allstate Corporation held 80,947 shares of Colgate-Palmolive worth $6.9M as of Q1 2026.
- Allstate Corporation bought 23,889 Colgate-Palmolive shares in Q1 2026, an estimated $2.13M.
- Colgate-Palmolive made up 0.07% of Allstate Corporation's portfolio in Q1 2026, its #175 holding.
- Allstate Corporation first reported a position in Colgate-Palmolive in Q2 2016 and has held it in 26 quarters since.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.